Sunday, December 22, 2024

Canada’s Politics and Government News Source Since 1989

Sunday, December 22, 2024 | Latest Paper

Canada must move quickly for a successful rare disease strategy

There are still a few key pieces missing to ensure the 3.2 million Canadians living with rare diseases get faster access to the treatments they need.

Opinion
BY GABY BOURBARA
June 12, 2023

Opinion | BY GABY BOURBARA | June 12, 2023

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Hundreds of billions in ‘contingent liabilities’ loom large over Canada

OpinionBY TOM FLANAGAN

Justin Trudeau no longer has a mandate to govern, and he doesn’t care

OpinionBY JAKE ENWRIGHT

Canada needs a stable democratic partner in South Korea

OpinionBY MIKE DANAGHER

What Canada needs in its next prime minister

OpinionBY JOSEPH INGRAM

Like it or not, the die is cast

OpinionBY MICHAEL HARRIS

Related Stories

Doctors need the right tools to treat patients well, especially for rare diseases

OpinionBY SANJAY MEHTA

A year later, none of the $1.5B for rare disease has flowed to patients

OpinionBY DAVID RENWICK

Building a successful rare disease strategy is our shared responsibility: stakeholder

Canada needs its rare disease strategy to get the health-care system back on track

OpinionBY CHRISTIAN HANSEN

‘Disappointing’ budget leaves gaps in health research in coming year, says health network

NewsBY JESSE CNOCKAERT

Doctors need the right tools to treat patients well, especially for rare diseases

OpinionBY SANJAY MEHTA

The federal government must prioritize the health of Canadians affected by rare diseases, and release the promised funds for medicines to treat these conditions.

Doctors need the right tools to treat patients well, especially for rare diseases

OpinionBY SANJAY MEHTA

The federal government must prioritize the health of Canadians affected by rare diseases, and release the promised funds for medicines to treat these conditions.

A year later, none of the $1.5B for rare disease has flowed to patients

OpinionBY DAVID RENWICK

Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.

A year later, none of the $1.5B for rare disease has flowed to patients

OpinionBY DAVID RENWICK

Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.

Building a successful rare disease strategy is our shared responsibility: stakeholder

Building a successful rare disease strategy is our shared responsibility: stakeholder

Canada needs its rare disease strategy to get the health-care system back on track

OpinionBY CHRISTIAN HANSEN

Canada needs its rare disease strategy to get the health-care system back on track

OpinionBY CHRISTIAN HANSEN

‘Disappointing’ budget leaves gaps in health research in coming year, says health network

NewsBY JESSE CNOCKAERT

‘Disappointing’ budget leaves gaps in health research in coming year, says health network

NewsBY JESSE CNOCKAERT